Short answer
MAXCYTE, INC. (MXCT) filed an 8-K current report with the SEC on June 16, 2026 reporting Item 3.01 (Notice of Delisting). Nasdaq minimum bid-price deficiency cured after 10 consecutive business days at or above $1.00.
- This filing includes Item 3.01, an item that often signal trouble.
MAXCYTE, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 3.01 · Notice of Delisting
- Nasdaq minimum bid-price deficiency cured after 10 consecutive business days at or above $1.00
- Compliance period ran May 27–June 9, 2026
- Nasdaq delisting matter closed, preserving Nasdaq Global Select Market listing
- Prior deficiency followed 30 consecutive trading days below $1.00, highlighting renewed listing-compliance risk
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other MAXCYTE, INC. 8-K filings
Get the next MXCT 8-K as it lands
Follow MXCT for push alerts, or ask the research agent what this filing means.